123 related articles for article (PubMed ID: 37357953)
1. Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors.
Schlein LJ; Thamm DH
Vet Pathol; 2024 Jan; 61(1):20-31. PubMed ID: 37357953
[TBL] [Abstract][Full Text] [Related]
2. Review: NF-kB activation in canine cancer.
Schlein LJ; Thamm DH
Vet Pathol; 2022 Sep; 59(5):724-732. PubMed ID: 35499088
[TBL] [Abstract][Full Text] [Related]
3. Cytologic identification of erythrophagocytic neoplasms in dogs.
Barger AM; Skowronski MC; MacNeill AL
Vet Clin Pathol; 2012 Dec; 41(4):587-9. PubMed ID: 23016693
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
5. Parthenolide As a Therapeutic for Disseminated Canine Neoplasms.
Schlein LJ; Brill SA; Brady RV; Farrell KB; Rose BJ; Meuten TK; Jordan CT; Thamm DH
J Pharmacol Exp Ther; 2024 Feb; 388(3):774-787. PubMed ID: 38135509
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
Ok CY; Xu-Monette ZY; Li L; Manyam GC; Montes-Moreno S; Tzankov A; Visco C; Dybkær K; Routbort MJ; Zhang L; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Rao H; Møller MB; Winter JN; Piris MA; Wang SA; Medeiros LJ; Young KH
Mod Pathol; 2015 Sep; 28(9):1202-13. PubMed ID: 26111978
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.
Kang MR; Kim MS; Kim SS; Ahn CH; Yoo NJ; Lee SH
Pathology; 2009; 41(7):622-5. PubMed ID: 20001340
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors.
Ramos-Vara JA; Miller MA
Vet Pathol; 2011 May; 48(3):758-63. PubMed ID: 21285383
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI; Beg AA; Baldwin AS
Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
[TBL] [Abstract][Full Text] [Related]
10. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville MP; Bours V
Oncogene; 1995 Nov; 11(9):1835-41. PubMed ID: 7478612
[TBL] [Abstract][Full Text] [Related]
11. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100.
Murakami T; Hirai H; Suzuki T; Fujisawa J; Yoshida M
Virology; 1995 Feb; 206(2):1066-74. PubMed ID: 7856081
[TBL] [Abstract][Full Text] [Related]
13. Morphology and immunophenotype of canine cutaneous histiocytic tumours with particular emphasis on diagnostic application.
Paździor-Czapula K; Rotkiewicz T; Otrocka-Domagała I; Gesek M; Śmiech A
Vet Res Commun; 2015 Mar; 39(1):7-17. PubMed ID: 25563490
[TBL] [Abstract][Full Text] [Related]
14. Regulation of activity and function of the p52 NF-κB subunit following DNA damage.
Barré B; Coqueret O; Perkins ND
Cell Cycle; 2010 Dec; 9(24):4795-804. PubMed ID: 21131783
[TBL] [Abstract][Full Text] [Related]
15. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes.
Ohmae T; Hirata Y; Maeda S; Shibata W; Yanai A; Ogura K; Yoshida H; Kawabe T; Omata M
J Immunol; 2005 Dec; 175(11):7162-9. PubMed ID: 16301619
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.
Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Manfredi MJ; Sorenmo KU
Vet Pathol; 2005 May; 42(3):350-3. PubMed ID: 15872381
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
